News & Press Releases

Viela Bio announced it has incorporated as an independent inflammation- and autoimmunity-focused biotechnology company after spinning out six molecules from MedImmune, the global biologics research and development arm of AstraZeneca.

Mintz is expanding the firm’s technology capabilities with the arrival of William S. Perkins and Dinesh K. Melwani. Both join as Members in the Corporate & Securities Section and will help lead the firm’s technology initiative from Boston.

Bruce Sokler, the Chair of Mintz’s Antitrust practice, was quoted in Law360’s article on a February 26th Supreme Court case regarding a dispute over anti-steering provisions in American Express merchant agreements.

Adam Lenain, a member of Mintz’s San Diego office, counsels technology companies, both public and private, on matters including mergers and acquisitions, licensing and collaborations, and general corporate and securities issues.

Mintz attorney Patricia Moran’s article was recently published on the Society for Human Resource Management’s website. In it, she elaborates on the matter of cybersecurity awareness, or lack thereof, when it comes to employer management of 401(k) plans.